Robert Kim - Chief Medical Officer at 4D Molecular Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
FDMT on Nasdaq
All Insider Reports
All Insider Reports

Robert Kim - trading volume in the past year for 4D Molecular Therapeutics, Inc.

Holdings reported by Robert Kim for 4D Molecular Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.6K $29.4K $18.41 Feb 7, 2024 Direct
Stock Option (Right to Buy) 54K Feb 5, 2024 Direct Common Stock

Transactions reported by Robert Kim for 4D Molecular Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.